Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Seroprevalence of Hand, Foot and Mouth Disease Among Children and Adolescents in Türkiye.

Vaccines·2026

Same author

A comparative analysis of pediatric <i>Klebsiella oxytoca</i> and <i>Klebsiella pneumoniae</i> bacteremia: clinical characteristics, antimicrobial susceptibility, and outcomes.

Infectious diseases (London, England)·2026

Same author

Clinical impact of toxin detection in children with PCR-confirmed Clostridioides difficile infection.

European journal of pediatrics·2026

Same author

Epidemiological trends of Pediatric scabies in Central Anatolia: a retrospective analysis covering the period 2019-2023.

International journal of environmental health research·2026

Same author

Catheter-Related Septic Embolism in Pediatric Hemodialysis.

Turkish archives of pediatrics·2026

Same author

Burden, Risk Factors, and Clinical Outcomes of Pediatric Influenza in a Population with Extremely Low Vaccine Coverage.

Turkish archives of pediatrics·2026

Search research articles

Related Experiment Video

Updated: Jan 31, 2026

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

Pediatric cases caused by Streptococcus pneumoniae Serotype 3.

Aslinur Ozkaya-Parlakay¹, Meltem Polat², Belgin Gulhan¹

¹a Pediatric Infectious Diseases Unit , Health Sciences University Ankara Hematology and Oncology Research Hospital , Ankara , Turkey.

Human Vaccines & Immunotherapeutics

|December 25, 2018

Summary

Streptococcus pneumoniae causes invasive pneumococcal disease (IPD). High vaccination coverage and surveillance are crucial to reduce both vaccine and non-vaccine serotype carriage and track evolving pneumococcal epidemiology.

Keywords:

invasive pneumococcal disease pediatric serotype 3

More Related Videos

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Related Experiment Videos

Last Updated: Jan 31, 2026

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Area of Science:

Microbiology
Epidemiology
Public Health

Background:

Streptococcus pneumoniae is a significant global cause of invasive pneumococcal disease (IPD), contributing to substantial morbidity and mortality.
While non-vaccine serotypes are a concern, serotypes covered by the 13-valent pneumococcal conjugate vaccine (PCV13) also remain problematic.

Purpose of the Study:

To highlight the ongoing challenges posed by both vaccine and non-vaccine serotypes of Streptococcus pneumoniae in IPD.
To emphasize the importance of high vaccination coverage and multicenter surveillance for controlling pneumococcal disease.

Main Methods:

The study reviews current epidemiological data on IPD.
It discusses the impact of existing vaccination strategies (PCV13) on serotype prevalence.
It advocates for enhanced surveillance systems.

Main Results:

Despite PCV13, certain vaccine serotypes continue to cause IPD.
Non-vaccine serotypes represent a persistent challenge in pneumococcal epidemiology.
High vaccination coverage is essential for reducing overall pneumococcal carriage.

Conclusions:

Sustained high vaccination coverage is necessary to decrease carriage of both vaccine and non-vaccine pneumococcal serotypes.
Multicenter surveillance studies are vital for monitoring shifts in pneumococcal seroepidemiology and guiding public health interventions.